| CHRNG |
CHRNG, ACHRG: Acetylcholine receptor subunit gamma precursor |
CHRND |
CHRND, ACHRD: Acetylcholine receptor subunit delta precursor |
0.305 |
Evidence |
|
| CHMP7 |
CHMP7: Charged multivesicular body protein 7 |
CHMP2B |
CHMP2B, CGI-84: Charged multivesicular body protein 2b |
0.305 |
Evidence |
|
| HCRTR1 |
HCRTR1: Orexin receptor type 1 |
GNAT1 |
GNAT1, GNATR: Guanine nucleotide-binding protein G(t), alpha-1 subunit |
0.305 |
Evidence |
|
| GABRR2 |
GABRR2: Gamma-aminobutyric acid receptor subunit rho-2 precursor |
CHRNE |
CHRNE, ACHRE: Acetylcholine receptor subunit epsilon precursor |
0.305 |
Evidence |
|
| CHRND |
CHRND, ACHRD: Acetylcholine receptor subunit delta precursor |
CHRNA6 |
CHRNA6: Neuronal acetylcholine receptor subunit alpha-6 precursor |
0.305 |
Evidence |
|
| KCNA6 |
KCNA6: Potassium voltage-gated channel subfamily A member 6 |
TRPC3 |
N-terminally extended type 3 canonical transient receptor potential channel |
0.305 |
Evidence |
|
| SERPINB10 |
SERPINB10, PI10: Serpin B10 |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.305 |
Evidence |
|
| CHRNB1 |
CHRNB1, ACHRB, CHRNB: Acetylcholine receptor subunit beta precursor |
CHRND |
CHRND, ACHRD: Acetylcholine receptor subunit delta precursor |
0.305 |
Evidence |
|
| TNFSF8 |
TNFSF8, CD30L, CD30LG: Tumor necrosis factor ligand superfamily member 8 |
EDA2R |
EDA2R, TNFRSF27, UNQ2448/PRO34080/PRO5727, XEDAR: Tumor necrosis factor receptor |
0.305 |
Evidence |
|
| TEP1 |
TEP1, TLP1, TP1: Telomerase protein component 1 |
IRAK4 |
IRAK4: Interleukin-1 receptor-associated kinase 4 |
0.305 |
Evidence |
|
| C2 |
C2: Complement C2 precursor |
SERPINB10 |
SERPINB10, PI10: Serpin B10 |
0.305 |
Evidence |
|
| GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
GPR44 |
GPR44, CRTH2, DL1R: Putative G-protein coupled receptor 44 |
0.305 |
Evidence |
|
| GABRD |
GABRD: Gamma-aminobutyric acid receptor subunit delta precursor |
GABRA1 |
GABRA1: Gamma-aminobutyric acid receptor subunit alpha-1 precursor |
0.305 |
Evidence |
|
| GLRA2 |
GLRA2: Glycine receptor subunit alpha-2 precursor |
CHRNA5 |
NACHRA5, CHRNA5: Neuronal acetylcholine receptor subunit alpha-5 precursor |
0.305 |
Evidence |
|
| CACNA1B |
CACNA1B, CACH5, CACNL1A5: Voltage-dependent N-type calcium channel subunit alpha |
HCN4 |
HCN4: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated chann |
0.305 |
Evidence |
|
| RNH1 |
RNH1, PRI, RNH: Ribonuclease inhibitor |
CARD4 |
NOD1, CARD4: Nucleotide-binding oligomerization domain-containing protein 1 |
0.305 |
Evidence |
|
| CHRNA4 |
CHRNA4, NACRA4: Neuronal acetylcholine receptor subunit alpha-4 precursor |
CHRNE |
CHRNE, ACHRE: Acetylcholine receptor subunit epsilon precursor |
0.305 |
Evidence |
|
| STX18 |
STX18, GIG9: Syntaxin-18 |
SYBL1 |
SYBL1: Synaptobrevin-like protein 1 |
0.305 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
GPR87 |
GPR87, GPR95, FKSG78: Probable G-protein coupled receptor 87 |
0.305 |
Evidence |
|
| BCL2L2 |
BCL2L2, BCLW, KIAA0271: Apoptosis regulator Bcl-W |
BCL2L13 |
BCL2L13, MIL1, CD003: Bcl-2-like 13 protein |
0.305 |
Evidence |
|
| HCRTR1 |
HCRTR1: Orexin receptor type 1 |
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
0.305 |
Evidence |
|
| GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
GPR20 |
GPR20: Probable G-protein coupled receptor 20 |
0.305 |
Evidence |
|
| CHRND |
CHRND, ACHRD: Acetylcholine receptor subunit delta precursor |
GABRG3 |
GABRG3: Gamma-aminobutyric acid receptor subunit gamma-3 precursor |
0.305 |
Evidence |
|
| KCNA6 |
KCNA6: Potassium voltage-gated channel subfamily A member 6 |
SCN11A |
SCN11A, PN5, SCN12A, SNS2: Sodium channel protein type 11 subunit alpha |
0.305 |
Evidence |
|
| SERPINB10 |
SERPINB10, PI10: Serpin B10 |
HP |
HP: Haptoglobin precursor [Contains: Haptoglobin alpha chain; Haptoglobin beta c |
0.305 |
Evidence |
|
- 
- 
-